Advertisement
Enzo Biochem, Inc.

Enzo Biochem, Inc. (ENZ) Stock Overview

Explore Enzo Biochem, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

ENZโ—NYSE
HealthcareMedical - Diagnostics & Research
$0.31
$0.02(6.08%)
U.S. Market is Open ยท 14:57
Advertisement

Enzo Biochem, Inc. (ENZ)

Meyka AI Score

Z

Key Financials

Market Cap16.4M
P/E Ratio-3.80
EPS (TTM)$-0.11
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ENZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Enzo Biochem, Inc. (ENZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.80 and a market capitalization of 16.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-42.89%
5-Day Change
-37.24%
1-Month Change
N/A
3-Month Change
-37.44%
6-Month Change
-69.83%
Year-to-Date (YTD) Change
-56.42%
1-Year Change
-71.21%
3-Year Change
-87.35%
5-Year Change
-89.22%
All-Time (Max) Change
-54.58%

Contact Information

212 583 0100
527 Madison Avenue, New York City, NY, 10022

Company Facts

1,250 Employees
IPO DateJun 12, 1980
CountryUS

Frequently Asked Questions